Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2014-01-17 | By Order of the Board of Directors /s/ Jennifer K. Simpson Jennifer K. Simpson Interim Co-President and Co-Chief Executive Officer, Executive Vice President, Global Head of Business Operations |
| Filing Date | Source Excerpt |
|---|---|
| 2021-04-30 | Jennifer Simpson 2020 71,250 302,681 373,931 The following table sets forth in summary form information regarding the compensation earned for service on our Board during the year ended December 31, 2020 by our directors who were not also our employees. |
| 2022-06-15 | Dr. Jennifer K. Simpson, Ph.D., MSN, CRNP has served as a member of our Board since August 2019. Dr. Simpson also serves as a director of CytRx Corporation. She serves as Chief Executive Officer and on the board of directors of Panbela Therapeutics, Inc. Dr. Simpson is a member of our nominating and corporate governance committee and strategic clinical development committee. Her 2021 total compensation was $405,136 as shown in the Director Compensation Table. |
| 2023-05-01 | Jennifer K. Simpson (2)(3)(4) Member of our compensation committee, Member of our nominating and corporate governance committee, Member of our strategic clinical development committee. |
Data sourced from SEC filings. Last updated: 2025-12-07